Jasmin Lipat Sullivan, APRN

Jasmin Sullivan practices at Guam Radiology Consultants in Honolulu, Hawaii.

Jasmin Sullivan's NPI, 1053096081, was assigned on June 19, 2023. Jasmin Sullivan holds Florida license APRN11027004.

Jasmin Sullivan's primary practice is Guam Radiology Consultants, at 459 Patterson Rd, Honolulu, HI 96819. The practice phone is (671) 649-1001.

Jasmin Sullivan's primary practice is Guam Radiology Consultants in Honolulu, Hawaii. The medical group on file is Guam Radiology Consultants. Dmand AI also links Jasmin Sullivan to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jasmin Sullivan practices. Vendor and product names are available with a free account.

Primary care is Jasmin Sullivan's primary specialty in the NPI Registry, under taxonomy code 363LP2300X. Jasmin Sullivan is licensed in Florida.

Dmand AI lists chronic nasal allergies among the conditions Jasmin Sullivan treats.

CMS data shows 57 Medicare services from Jasmin Sullivan across 2 procedure codes in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $3,773 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Jasmin Sullivan in 2024. The largest group is 75 to 84, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jasmin Sullivan's median patient age at 66, with 30% women.

In 2024, Jasmin Sullivan wrote 2,292 Medicare Part D claims for 516 patients. 91% of them were for generic drugs. CMS names the drug for 1,744 of them, across 60 drugs with 11 or more claims each, at $46,100 in total drug cost.

Jasmin Sullivan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jasmin Sullivan as offering telehealth.

CMS Open Payments shows 1 general payment to Jasmin Sullivan from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $19.